Loading company…
Riskpilot
← Back to search
Sign in
Get full access
eyeCo Scandinavia AB
AB
Active
Org 5593096190
Backegårdsvägen 2
Wholesale of pharmaceutical and medical goods · NACE 4646
Est. 2021
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
SEK 5K
-61% vs 2023
EBITDA margin
-1048.2%
-20% vs 2023
Equity ratio
37.3%
Financial strength
Net profit 2024
SEK 3K
+214% vs 2023
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
SEK 5K
-61%
EBITDA
SEK -50K
-20%
Net profit
SEK 3K
+214%
Total assets
SEK 144K
-19%
Equity
SEK 54K
+7%
Employees
0
—
Company information
Legal name
eyeCo Scandinavia AB
Org number
5593096190
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
26 mars 2021
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Försäljare av optiska tillbehör och utrustning.
Contact
Address
Backegårdsvägen 2
Email
dbansal@innz.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of pharmaceutical and medical goods
Companies in Uddevalla
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
SEK thousands
Item
2021
2022
2023
2024
Revenue
97
91
12
5
Staff expenses
—
—
—
—
EBITDA
−22
−5
−42
−50
Depreciation & amort.
−0
—
—
—
EBIT
−22
−5
−42
−50
Net financials
—
−0
1
−0
Profit before tax
0
−0
1
4
Tax
−0
—
—
−1
Net profit
0
−0
1
3
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
Total assets
87
121
177
144
Equity
50
49
50
54
Long-term debt
0
—
—
—
Short-term debt
37
72
127
90
Total debt
37
72
127
90
Financial ratios
5-year trend
EBITDA margin
-1048.2%
This company
15.8%
Market median
-6734% vs market
2021
2024
Equity ratio
37.3%
This company
38.2%
Market median
+2% vs market
2021
2024
Return on equity
6.4%
This company
18.4%
Market median
-65% vs market
2021
2024
Net profit margin
71.5%
This company
8.1%
Market median
+783% vs market
2021
2024
Asset turnover
0.03×
This company
1.12×
Market median
-97% vs market
2021
2024
Debt / equity
1.68×
This company
0.62×
Market median
-171% vs market
2021
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-03-01 – 2021-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (2)
BS
Bo Stefan Carlsson
Audit
Audit
2022
SV
Sandra Viktoria Wallström
Chief Executive Officer
Chief Executive Officer
2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
DB
Dheeraj Bansal
Board of Directors
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of eyeCo Scandinavia AB also hold positions in
0
other companies.
Person
Role here
Other companies
Bo Stefan Carlsson
Audit
0 companies
Sandra Viktoria Wallström
Chief Executive Officer
0 companies
Dheeraj Bansal
Board of Directors
0 companies